Breaking News
December 13, 2018 - Drug repositioning strategy identifies potential new treatments for epilepsy
December 13, 2018 - Chronic rhinitis associated with hospital readmissions for asthma and COPD patients
December 13, 2018 - Food poisoning discovery could save lives
December 13, 2018 - Cloned antibodies show potential to treat, diagnose life-threatening fungal infections
December 13, 2018 - Exercise may reduce colorectal cancer risk after weight loss
December 13, 2018 - Russian scientists create hardware-information system for brain disorders treatment
December 13, 2018 - Moderate alcohol consumption linked with lower risk of hospitalization
December 13, 2018 - Nurturing Healthy Neighborhoods | NIH News in Health
December 13, 2018 - Rise in meth and opioid use during pregnancy
December 13, 2018 - Researchers gain new insights into pediatric tumors
December 13, 2018 - FSU study finds racial disparity among adolescents receiving flu vaccine
December 13, 2018 - Drug cocktail induces cancer cell death by switching off energy supply
December 13, 2018 - Baculovirus virion completely eliminates liver-stage parasites in mouse model
December 13, 2018 - Researchers create noninvasive technology that detects when nerve cells fire
December 13, 2018 - Treating patients with hypertension induced albuminuria
December 13, 2018 - New substance could improve efficacy of established breast cancer treatments
December 13, 2018 - Scientists develop new stem cell line to study conversion of stem cells into muscle
December 13, 2018 - Re-programming the body’s energy pathway boosts kidney self-repair
December 13, 2018 - Research findings could help improve treatment of anxiety and post-traumatic stress disorders
December 13, 2018 - The Microbiome Movement announce Microbiotica as official industry partner
December 13, 2018 - New study reveals potential benefits of cEEG monitoring for infant ICU patients
December 13, 2018 - Whole-body imaging PET/MRI offers information to guide treatment options for prostate cancer
December 13, 2018 - International investigators fight against the negative campaign on benzodiazepines
December 13, 2018 - Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders
December 13, 2018 - FDA Approves Tolsura (SUBA®-itraconazole capsules) for the Treatment of Certain Fungal Infections
December 13, 2018 - Are scientists studying the wrong kind of mice?
December 13, 2018 - Computer memory: A scientific team builds a virtual model of a key brain region
December 13, 2018 - Visual inspection alone is insufficient to diagnose skin cancer
December 13, 2018 - Paternal grandfather’s access to food associated with grandson’s mortality risk
December 13, 2018 - Our brain senses angry voices in a flash, study shows
December 13, 2018 - PM2.5 Exposure Linked to Asthma Rescue Medication Use
December 13, 2018 - Can’t exercise? A hot bath may help improve inflammation, metabolism, study suggests
December 13, 2018 - Can artificial intelligence help doctors with the human side of medicine?
December 13, 2018 - Virginia Tech and UC San Diego researchers team up to develop nonopioid drug for chronic pain
December 13, 2018 - NIH offers support for HIV care and prevention research in the southern United States
December 12, 2018 - Activating brain region could revive the urge to socialize among opioid addicts
December 12, 2018 - Relationship impairment appears to interfere with seeking mental health treatment in men
December 12, 2018 - Sleep, Don’t Cram, Before Finals for Better Grades
December 12, 2018 - Effective treatments for urticarial vasculitis
December 12, 2018 - Gun violence is a public health issue: One physician’s story
December 12, 2018 - The Science of Healthy Aging
December 12, 2018 - Yes to yoghurt and cheese: New improved Mediterranean diet
December 12, 2018 - Researchers uncover a number of previously unknown insecticide resistance mechanisms
December 12, 2018 - Regulating the immune system’s ‘regulator’
December 12, 2018 - In breaking bad news, the comfort of silence
December 12, 2018 - Study finds upward link between alcohol consumption and physical activity in college students
December 12, 2018 - FDA issues warning letter to Zhejiang Huahai Pharmaceutical involved in valsartan recall
December 12, 2018 - Weight history at ages 20 and 40 could help predict patients’ future risk of heart failure
December 12, 2018 - Presence of antiphospholipid antibodies tied to first-time MI
December 12, 2018 - DNA analysis finds that stethoscopes are teaming with bacteria
December 12, 2018 - New study could help inform research on preventing falls
December 12, 2018 - Women and men with heart attack symptoms receive different care from EMS
December 12, 2018 - Disrupted biological clock can contribute to onset of diseases, USC study shows
December 12, 2018 - New publications generate controversy over the value of reducing salt consumption in populations
December 12, 2018 - New data from TAILORx trial confirms lack of chemo benefit regardless of race or ethnicity
December 12, 2018 - Specific class of biomarkers can accurately indicate the severity of cancer
December 12, 2018 - Meds Taken Do Not Vary With ADL Impairment in Heart Failure
December 12, 2018 - Long-term study shows that HIV-2 is deadlier than previously thought
December 12, 2018 - People living near oil and gas wells show early signs of cardiovascular disease
December 12, 2018 - IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony
December 12, 2018 - People who eat red meat have high levels of chemical associated with heart disease, study finds
December 12, 2018 - New method uses water molecules to unlock neurons’ secrets
December 12, 2018 - Genetics study offers hope for new acne treatment
December 12, 2018 - New computer model predicts prostate cancer progression
December 12, 2018 - Nobel Laureates lecture about immune checkpoint therapy for cancer treatment
December 12, 2018 - More Illnesses From Tainted Romaine Lettuce Reported
December 12, 2018 - Aspirin could reduce HIV infections in women
December 12, 2018 - The EORTC Brain Tumor Group and Protagen AG collaborate to study immuno-competence of long-term glioblastoma survivors
December 12, 2018 - Insights into magnetotactic bacteria could guide development of biological nanorobots
December 12, 2018 - Sacrificial immune cells alert body to infection
December 12, 2018 - Low-salt diet may be more beneficial for females than males
December 12, 2018 - Major soil organic matter compound battles chronic wasting disease
December 12, 2018 - Findings may open up new ways to treat dwarfism and other ER-stress-related conditions
December 12, 2018 - New computational model provides clearer picture of shape-changing cells’ structure and mechanics
December 12, 2018 - 10 Facts on Patient Safety
December 12, 2018 - Poorest dying nearly 10 years younger than the rich in ‘deeply worrying’ trend for UK
December 12, 2018 - Innovative care model for children with ASD reduces use of behavioral drugs in ED
December 12, 2018 - Spending time in and around Hong Kong’s waters linked to better health and wellbeing
December 12, 2018 - Simple measures to prevent weight gain over Christmas
December 12, 2018 - Research advances offer hope for patient-tailored AML treatment
Monitoring the Environment of Aseptic Processes

Monitoring the Environment of Aseptic Processes

image_pdfDownload PDFimage_print

An interview with Lisa G. Lawson, MS- Global Pharma GMP Advisor at Particle Measuring Systems.

Please define the meaning of “risk” from the perspective of environmental monitoring.

Risk assessment consists of the identification of hazards and the analysis and evaluation of risks associated with exposure to those hazards. The risk assessment of particle and microbiological samples should consider:

  • Highest risk of contamination of the product and its components (study of the airflows and exhaust grid)
  • Personnel operations
  • Material and personnel flows
  • Cleaning and sanitizing of environments and equipment

Credit: CoolaM/

What are the stages of an aseptic process and which point is most vulnerable to contamination?

Two clean areas are of particular importance to sterile drug product quality: the critical area and the supporting clean areas associated with it.

Critical areas are where the product is most susceptible to contamination. Most commonly, this is during manipulation of sterile materials before and during filling and closing operations (eg, asceptic connections or the addition of sterile ingredients).

Here, a sterilized drug product becomes exposed to the environment and presents the opportunity for contamination – if this occurs, the product will no longer be sterilized when it reaches the sterile container. Therefore, we take extra care in ensuring the critical area is especially designed to ensure product sterility.

Of course, it is important to maintain product sterility by controlling the environment that aseptic processes take place, at a suitable quality. However, it’s not often considered that an aspect of environmental quality is the particle content of the air.

Particles can not only enter and contaminate a product extraneously, but can also contaminate a previously sterile drug product by acting as a vehicle for microbial contamination. Therefore, the environment of which aseptic processes take place should contain suitably designed air handling systems to reduce the particle content within a critical area.

Please outline the FMEA method for microbial monitoring. How does it identify and evaluate risk?

Quality Risk Management (QRM) activities are performed using systematic processes designed to coordinate, facilitate and improve science-based decision-making with respect to risk.

The analysis of the risk assessment is carried out using the FMEA method – the typical mathematical relationship that links the “Risk” RPI (Risk Priority Index) with the “Probability of contamination”, the “severity” of the expected damage, and the “Detectability” of the damage, summarized as: RPI = P1 x P2 x S x D.

  • P1 = The estimate of the probability of environmental contamination
  • P2 = The estimate of the probability of product contamination
  • S = Severity which defines the importance of danger on the basis of its consequences
  • D = The ability to detect any particles present in the environment through the use of different monitoring methods

How are levels of risk measured and what are the criteria for these?

The following is a typical matrix used to evaluate risk:

Therefore, the risk for controlled environments is defined as:

Following this analysis, you proceed to the next step which involves risk control. Risk control is a decision-making activity designed to reduce or accept risks of the existing microbiological/particle control.

The purpose of risk control is to reduce the risk to an acceptable level. Risk reduction includes all the actions to be taken to reduce the probability of contamination value or increase detectability value by employing specific methods of sampling.

What service can Particle Measuring Systems provide for sterility assurance?

Particle Measuring Systems provide our customers with the tools to ensure sterility of their products through comprehensive analysis and robust final documentation. We work closely with pharmaceutical companies to promote sterility education and successful procedure implementation.

We provide support on sterility assurance deviations, pharmaceutical process design evaluation and risk analysis, US and international regulatory audit support, and quality crisis management (warning letter and 483 observation response support).

If a risk is identified, how can the environment be altered to eliminate it? How easy is it to do this?

The purpose of risk control is to reduce the risk to an acceptable level.  Risk reduction includes all the actions to be taken to reduce the probability of contamination value or increase detectability value by employing specific methods of sampling.  These sampling methods may include: volumetric air sampling, settle plates, surface sampling and total particle air sampling

Do Particle Measuring Systems offer any support to help customers change their production process to eliminate any risks identified by using the service?

We offer support in many areas including but not limited to:

Training and certification in:

  1. Fundamentals of Microbiology
  2. Personnel Hygiene GMP practices
  3. Contamination Control
  4. Cleanroom qualification training
  5. Cleaning and Sanitization GMP practices
  6. Alternative Microbiological Methods training
  7. Risk Assessment use in contamination control
  8. Media Fill Requirements training
  9. FDA and EU guideline interpretation training
  10. Regulatory Update training
  11. Any other training topic that can customized to meet customer needs

Sterility Assurance issues handling including:

  1. Development of a Corporate Sterility Assurance program
  2. Training, development or qualification for sterilization and/or depyrogenation
  3. Aseptic Process Management and/or facility design projects which may include:
  • Review of production deviations, non-conformities or other investigations
  • Validation of microbial sampling systems and isolators for sterility testing

Inspection Support and Management including:

  1. Resolution of FDA 483, EMA or local authority compliance deviations
  2. On-site support during regulatory inspections

Quality By Design (QbD)and Process Analytical Technology (PAT) support

  1. Providing advice on how QbD/PAT may be incorporated in the business system
  2. Applying comparability protocols and other regulatory strategies for deployment

Process and Methods Evaluation and/or Risk Assessment including:

  1. Performance of formal risk analysis using Failure Modes and Effects Analysis (FMEA), Hazard Analysis (HACCP) or other Risk Analysis Tool
  2. Evaluation of laboratories, production and quality operations
  3. Development of programs or procedures
  4. Review of data trends and recommendation of alert and action levels

Pharmaceutical Microbiology Support including:

  1. Environmental Monitoring evaluation and development
  2. Evaluation and development of protocols and cleaning procedures
  3. Evaluation and development of procedures, policies and standards for media fill
  4. Microbiological Data Deviations (MDD) and analysis of Out-of-Specification (OOS)
  • Program Development and review of microbiological data deviations and OOS
  • Implementation of corrective action plans for reducing and/or eliminating MDD or OOS

Production and Quality Assurance Support including:

  1. Process Optimization, or project management assistance
  2. Comparability Protocols for process/analytical changes
  3. Cleaning and sanitization process analysis including practices, procedures and rationales/rotations
  4. Development of Quality Management System (QMS)
  5. Evaluation of systems based inspection compliance programs
  6. Support implementation of quality problem solving tools
  7. Assist in investigation resolution, reduction and root cause analysis

Quality Control Support including:

1.Laboratory Management

  • Optimization of laboratory policies, procedures, equipment and methods
  • Sterility test analysis and evaluation of positive sterility failure tests

2.Development of rapid methods for sterility testing

How often are sterility assurance methods reviewed or improved?

Once risk control measures have been identified, it is important to ensure all stakeholders are aware of the risks identified and are in alignment with the mitigation measures employed to reduce risk. Therefore, the last steps in the QRM process are risk communication and periodic risk review.

Risk communication is the sharing of information about risk and risk management between decision makers and others. Parties can communicate at any stage of the risk management process. The output/result of the quality risk management process should be appropriately communicated and documented.

Appropriate systems should be in place to ensure that the output of the QRM process is periodically monitored and reviewed, as appropriate, to assess new information that may impact the original QRM decision. Examples include changes to control systems, equipment and processes, suppliers or contractors and organizational restructuring.

What does the future hold for the development of environmental risk assessment? Will processes become completely automated?

The future for environmental risk assessment is to automate processes as much as possible to further reduce the risk of personnel contamination, as human interventions pose the greatest particulate and microbiological contamination risk to the product.

Where can readers find more information?

Please find more information on our Advisory services at the following link:

To view our full line of innovative environmental monitoring products, go to:

About Lisa Lawson

Lisa G. Lawson has over 25 years’ experience in supporting large and small pharmaceutical companies in contamination control, including cleaning and disinfection strategies, aseptic manufacturing and use of risk-based approaches to microbiological quality challenges.

Lisa spent 16 years working for Amgen in microbial and mammalian cell culture manufacturing support and helped gain commercial FDA and international regulatory approval of the EPO/NESP manufacturing facility in Longmont, CO.


Tagged with:

About author

Related Articles